TAVIST ALLERGY/SINUS/HEADACHE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Tavist Allergy/sinus/headache, and when can generic versions of Tavist Allergy/sinus/headache launch?
Tavist Allergy/sinus/headache is a drug marketed by Novartis and is included in one NDA.
The generic ingredient in TAVIST ALLERGY/SINUS/HEADACHE is acetaminophen; clemastine fumarate; pseudoephedrine hydrochloride. There are sixty-six drug master file entries for this compound. Additional details are available on the acetaminophen; clemastine fumarate; pseudoephedrine hydrochloride profile page.
Summary for TAVIST ALLERGY/SINUS/HEADACHE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 179 |
| Patent Applications: | 5,220 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | TAVIST ALLERGY/SINUS/HEADACHE at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for TAVIST ALLERGY/SINUS/HEADACHE
US Patents and Regulatory Information for TAVIST ALLERGY/SINUS/HEADACHE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novartis | TAVIST ALLERGY/SINUS/HEADACHE | acetaminophen; clemastine fumarate; pseudoephedrine hydrochloride | TABLET;ORAL | 021082-001 | Mar 1, 2001 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
